| Old Articles: <Older 29551-29560 Newer> |
 |
The Motley Fool April 9, 2008 Timothy M. Otte |
Smiley-Faced Value for Wal-Mart? Wal-Mart stock is on a run -- can it go the distance?  |
The Motley Fool April 9, 2008 Rich Smith |
A Point Blank Proposal Body-armor manufacturer Point Blank Solutions announces it will "explore all strategic alternatives to enhance stockholder value."  |
The Motley Fool April 9, 2008 Rick Aristotle Munarriz |
Sleepy Days for Sealy Sealy beats the Street, but that doesn't mean the news was comforting.  |
Registered Rep. April 1, 2008 John Churchill |
UBS Projecting More Huge Write-Downs, Recapitalization In addition to the write-downs and recapitalization, it was also announced that long-time chairman Marcel Ospel will be stepping down at the end of the first quarter.  |
The Motley Fool April 8, 2008 Brian Lawler |
FDA Approvals ... Increase? So far in 2008, the agency has given more drugs a thumbs-up than this time in 2007. Take a look at which companies received approvals.  |
The Motley Fool April 8, 2008 Chris Hill |
Fool Video: Microsoft's Next Move? Should Microsoft raise its bid for Yahoo! or forget about it? Will Google or Time Warner rush in to save the day for Yahoo!? Or will News Corp. come to the table with a fair and balanced offer? A Yahoo! buyout is discussed in this video.  |
The Motley Fool April 8, 2008 Morgan Housel |
WaMu's $7 Billion Hospital Visit Washington Mutual will live to see another day. But it's hardly a time of celebration for the average shareholder.  |
The Motley Fool April 8, 2008 Rich Duprey |
First Marble-Headache First Marblehead's guarantor files for bankruptcy, raising questions of viability for the student loan provider.  |
The Motley Fool April 8, 2008 Rick Aristotle Munarriz |
Analysts Bite Into Apple Apple receives dueling opinions from Wall Street analysts this week, with a downgrade following an upgrade by mere hours.  |
The Motley Fool April 8, 2008 Brian Orelli |
Songs of the One-Drug Wonders Will these companies become big-name drugmakers or get lost in history? Let's take a quick look at: Abraxis Bioscience... Elan... Amylin Pharmaceuticals... Onyx Pharmaceuticals...  |
| <Older 29551-29560 Newer> Return to current articles. |